CVS Group has announced that it is intending to seek admission to trade on the Main Market of the London Stock Exchange (LSE).

The veterinary group has traded on the AIM since 2007 and delivered what it has described as "strong revenue and profit growth" and significant shareholder returns in this time.

CVS said that a move to the Main Market of the LSE would provide access to deeper pools of capital across a broader range of investors, offer the potential for index inclusion and enhance its corporate profile.

The firm said that it expects admission to the LSE in the first quarter of 2026, subject to approval from the Financial Conduct Authority.

Alongside this announcement, CVS launched a new £20m share buyback scheme, which commenced today.

The scheme is expected to be completed in Q1 2026.

The latest updates by CVS come after the Competition and Markets Authority (CMA) outlined reforms to the veterinary services market to support pet owners.

Chair at CVS, David Wilton, said: "The board has reached the decision to move up to the Main Market after carefully considering the merits and potential demerits of such move and evaluating the process involved. We believe it is, as a listed company, in CVS's best interest to do so as it will provide access to deeper pools of capital across a broader range of investors, offer the potential for index inclusion, improve trading liquidity, and enhance the group's corporate profile.

"We are grateful to our shareholders for their long-term support particularly through the period of uncertainty in the past two years since the CMA launched their market review in September 2023. We look forward to working with all our stakeholders in our next phase of growth."

---